Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia
Clinical trial NCT05128162 · COMPLETED
Trial details
- NCT number
- NCT05128162
- Sponsor
- Kevin Boehnke
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-27
- Primary completion
- 2024-06-12
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.